CNET [ChinaNet Online] NT 10-Q: (Original Filing)
[]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)
[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer May 15, 2012] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bing Mei Chief Financial Officer May 15, 2012]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q:
[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer May 15, 2012] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bing Mei Chief Financial Officer May 15, 2012]
CLNT [Cleantech Solutions International] 10-Q: FORM 10-Q (Mark One) x For the quarterly
[FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2012 o For the transition period from __________ to __________ CLEANTECH SOLUTIONS INTERNATIONAL, INC. DELAWARE 74-2235008 (State or other jurisdiction of (I.R.S. Employer incorporation of organization) Identification No.) No. 9 Yanyu Middle Road Qianzhou Township, Huishan District, Wuxi City], [SARBANES-OXLEY ACT OF 2002 I, Jianhua Wu, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of], [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER SARBANES-OXLEY ACT OF 2002 I, Wanfen Xu, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to], [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/Jianhua Wu Jianhua Wu ChiefExecutive Officer /s/Wanfen Xu Wanfen Xu ChiefFinancial Officer (Principal Accounting Officer)]
SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] 6-K: (Original Filing)
[SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION (Incorporated in the Cayman Islands with limited liability) (Stock code: 981) An official ceremony for the signing of the Cooperation Framework Document will be attended by, among others, Beijing officials and Mr. Zhang Wenyi, the Chairman of the Board of SMIC. BJEIT, BDAC and SMIC Beijing have agreed to negotiate in good faith with a view]
ALN [American Lorain] 10-Q: (Original Filing)
[FORM 10-Q (Mark One) Commission File No. 001-34449 AMERICAN LORAIN CORPORATION Nevada 87-0430320 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) Beihuan Road Junan County Shandong, China 276600 (86) 539-7318818 Yes [X] No [ ] Yes [ ] No [ ] Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [ ] Smaller reporting] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Si Chen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of American Lorain Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Section 302 of the Sarbanes-Oxley Act of 2002 I, David She, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of American Lorain Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [of the Sarbanes-Oxley Act of 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 15, 2012] [of the Sarbanes-Oxley Act of 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 15, 2012]
HIMX [Himax Technologies] F-6: PART I INFORMATION REQUIRED IN PROSPECTUS Item –
[PART I INFORMATION REQUIRED IN PROSPECTUS Item - 1. Description of Securities to be Registered] [TABLE OF CONTENTS ARTICLE 1. DEFINITIONS SECTION 1.01 American Depositary Shares. SECTION 1.02 Commission. SECTION 1.03 Company. SECTION 1.04 Custodian. SECTION 1.05 Deliver; Surrender. SECTION 1.06 Deposit Agreement. SECTION 1.07 Depositary; Corporate Trust Office. SECTION 1.08 Deposited Securities. SECTION 1.09 Dollars. SECTION 1.10 DTC.] [Writers Direct Dial LLP EMMET, MARVIN & MARTIN, COUNSELLORS AT LAW _____ 120 Broadway New York, New York 10271 _____ (212) 238-3000 (212) 653-1760 _____ Fax: (212) 238-3100 Fax: (212) 653-1730 http://www.emmetmarvin.com 177 MADISON AVENUE MORRISTOWN, NEW JERSEY 07960 (973) 538-5600 FAX: (973) 538-6448 May 15, 2012 The Bank of New York Mellon, as Depositary 101 Barclay Street New York,]
WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 2]
SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] 6-K: SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION (Incorporated in the Cayman
[SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION (Incorporated in the Cayman Islands with limited liability) (Stock code: 981) An official ceremony for the signing of the Cooperation Framework Document will be attended by, among others, Beijing officials and Mr. Zhang Wenyi, the Chairman of the Board of SMIC. BJEIT, BDAC and SMIC Beijing have agreed to negotiate in good faith with a view]
